Ethics of Drug Patents
January 11, 2016
Mike Fenwick writes for the January/February 2016 issue of Canadian Chemical News.
To read the article click here.
Content shared on Bereskin & Parr’s website is for information purposes only. It should not be taken as legal or professional advice. To obtain such advice, please contact a Bereskin & Parr LLP professional. We will be pleased to help you.
